Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2 - Summary - MDSpire

Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2

  • By

  • Selim Chaib

  • José Alberto López-Domínguez

  • Marta Lalinde-Gutiérrez

  • Neus Prats

  • Ines Marin

  • Olga Boix

  • Andrea García-Garijo

  • Kathleen Meyer

  • María Isabel Muñoz

  • Mònica Aguilera

  • Lidia Mateo

  • Camille Stephan-Otto Attolini

  • Susana Llanos

  • Sandra Pérez-Ramos

  • Marta Escorihuela

  • Fatima Al-Shahrour

  • Timothy P. Cash

  • Tamara Tchkonia

  • James L. Kirkland

  • María Abad

  • Alena Gros

  • Joaquín Arribas

  • Manuel Serrano

  • May 29, 2026

  • 0 min

Share

Objective:

To correct errors in the published figures related to the effects of palbociclib on SK-MEL-103 cells.

Key Findings:
  • Initial publication contained incorrect images for control and 5 μM palbociclib treatments.
  • Correct images have been included in the updated figure and additional Source Data file.
Interpretation:

Limitations:
  • The error occurred during figure preparation and may affect the interpretation of the original findings.
Conclusion:

The amended figure and new Source Data are now available in the HTML and PDF versions of the article.

Original Source(s)

Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2

  • by Selim Chaib, José Alberto López-Domínguez, Marta Lalinde-Gutiérrez, Neus Prats, Ines Marin, Olga Boix, Andrea García-Garijo, Kathleen Meyer, María Isabel Muñoz, Mònica Aguilera, Lidia Mateo, Camille Stephan-Otto Attolini, Susana Llanos, Sandra Pérez-Ramos, Marta Escorihuela, Fatima Al-Shahrour, Timothy P. Cash, Tamara Tchkonia, James L. Kirkland, María Abad, Alena Gros, Joaquín Arribas, Manuel Serrano

  • May 29, 2026

Related Content

Stimuli-responsive nanoplatforms for sonodynamic immunotherapy: opportunities and challenges in cancer treatment

Diffuse large B-cell lymphoma presenting as a scalp tumor with skull destruction and neurological symptoms: a case report

Understanding cardiac toxicity and immune responses to thoracic radiation therapy in non-small cell lung cancer – implications for future research